WinstonWınston
Back
Coloplast A/S logo

Coloplast A/S

CBHD.DE
58
Medical - Instruments & Supplies · Healthcare
Price
€58.66
+0.38 (+0.65%)
Market Cap
€13.22B
Exchange
Frankfurt Stock Exchange
Winston Score
58
Winston is curious
A decent business — some strong pillars, some weaker.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Strong
Growth
Weak
Cash Flow
Good
Stability
Good
Valuation
Good
Dividends
Good

Share count rising — dilution

+5.7% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 213.2M (2021) → 225.4M (2025)

Winston Score History

The full picture

Coloplast is a Danish medical device company that makes products for people with intimate health conditions — things like ostomy bags (for people who have had bowel surgery), catheters, wound care supplies, and continence products. Its customers are mostly patients, hospitals, and home care providers across the healthcare system. Coloplast is one of the largest companies in the world focused specifically on these types of personal medical needs.

The company sells its products directly to healthcare systems and through distributors, earning revenue from ongoing product purchases rather than one-time sales — patients typically need these supplies for life. Coloplast operates in over 40 countries, with Europe as its largest market and the United States as a key growth region, generating roughly $3 billion in annual revenue. Its main competitive advantages are strong brand loyalty among clinicians and patients, and deep specialization in a niche that larger medical device companies tend to avoid — though currency fluctuations and pricing pressure from healthcare systems remain ongoing risks.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
66.7%
Premium pricing power — 66.7% gross margin
Profit after running costs
Operating Margin
25.9%
Excellent — 25.9% operating margin
Return on the money invested
ROCE
20.5%
Exceptional — 20.5% return on capital

ROIC between 15% and 25%. Every dollar invested in the business earns 15 to 25 cents back per year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
-483.5%
Shrinking sales (-483.5% YoY)
Profit growth
EPS YoY
-32.3%
Earnings shrinking (-32.3% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

How steady the profit is
EPS Consistency
3/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
277%
Turns 277% of profit into real cash
Spare cash per sale
FCF Margin
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
1.73
Elevated debt (1.73)
Covers its interest
Interest Cover
10.26x
Comfortably covers interest (10.3x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
35.8x
Pricey — P/E 35.8

P/E over 35. The market is pricing in heavy, sustained growth.

Cheaper or dearer next year
P/E vs Forward
+20.3
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (35.8 → 15.5)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
2.28%
Moderate income — 2.28% yield

Standard yield zone for stable dividend payers. A meaningful piece of total return.

Dividend record
Dividend Growth
+9.7%
Dividend growing modestly (9.7% YoY)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial